Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
135 participants
INTERVENTIONAL
2000-01-31
2005-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Recombinant Human Leptin Therapy Effects on Insulin Action
NCT01207934
Semaglutide in Auto-HSCT
NCT06449625
Effect of Intranasal Insulin on Cognitive Processes and Appetite
NCT03632681
"Effect of Central Insulin Administration on Whole-body Insulin Sensitivity in Women"
NCT03929419
C-peptide Concentrations in Type 2 Diabetes Treated With Insulin; is it Time to Revise the Treatment of Type 2 Diabetes
NCT04005261
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Insulatard, flexpen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Systemic solid cancer
Exclusion Criteria
* Brain metastases
* Expectant survival of less than 6 months
* Serum creatinine above 200 umol/l
* Persistent of recurrent fever
* Cholestasis
25 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swedish Cancer Foundation
OTHER
Medical Research Council
OTHER_GOV
Göteborg University
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kent G Lundholm, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Surgery, Göteborg University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Surgery, Inst of Clinical Sciences
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wallengren O, Bosaeus I, Lundholm K. Dietary energy density, inflammation and energy balance in palliative care cancer patients. Clin Nutr. 2013 Feb;32(1):88-92. doi: 10.1016/j.clnu.2012.05.023. Epub 2012 Jun 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
kl450112
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.